Mar 13, 2017 7:00am EDT NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
Feb 22, 2017 7:00am EST NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
Feb 08, 2017 11:22am EST NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017
